$BMEA

$0.62 -$0.02 (2.83%) Live

$BMEA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$BMEA Management Team

Mr. Rainer Erdtmann

President

Co-Founder

Principal Financial Officer

Chief Operating Officer

Director

Age 61

Compensation $1.979M USD

Sex Male

Dr. Michael Hitchcock

Interim Chief Executive Officer

Director

Age 75

Compensation $241.5K USD

Sex Male

Dr. Juan Fras

Chief Medical Officer

Head of Diabetes

Age 61

Compensation $3.932M USD

Sex Male

Ms. Meichiel Jennifer Weiss

Senior Director

Investor Relations and Corporate Development

Age -

Compensation -

Sex Female

Name / Title	Age	Compensation	Sex
Mr. Rainer Erdtmann President Co-Founder Principal Financial Officer Chief Operating Officer Director	61	$1.979M USD	Male
Dr. Michael Hitchcock Interim Chief Executive Officer Director	75	$241.5K USD	Male
Dr. Juan Fras Chief Medical Officer Head of Diabetes	61	$3.932M USD	Male
Ms. Meichiel Jennifer Weiss Senior Director Investor Relations and Corporate Development	-	-	Female

Board of Directors

From the proxy statement filed Apr 27, 2026

Directors

serving now

Independent

4 of 6

stated in the proxy

Average tenure

5.0 years

from year joined

CEO also chairs the board

Not stated

no chair stated

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Rainer (Ramses) Erdtmann Executive officer	62	2017 9 years	Not independent	None stated	None stated	Not stated
Eric Aguiar Lead independent director	64	2020 6 years	Independent	Audit Committee Compensation Committee · Chair	BridgeBio Pharma, Inc.	$254,271
Michael J.M. Hitchcock CEO	76	2021 5 years	Not independent	None stated	None stated	Paid as CEO
Julianne Averill	41	2025 1 year	Independent	Audit Committee · Chair Compensation Committee Nominating and Corporate Governance Committee	None stated	$382,646
Elizabeth Faust	61	2022 4 years	Independent	Nominating and Corporate Governance Committee	None stated	Not stated
Sumita Ray	52	2021 5 years	Independent	Audit Committee Nominating and Corporate Governance Committee · Chair	None stated	$236,646

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 27, 2026 states there were none.

Read it in the proxy

Comments

Company Executives

$BMEA Management Team

Mr. Rainer Erdtmann

Dr. Michael Hitchcock

Dr. Juan Fras

Ms. Meichiel Jennifer Weiss

Board of Directors

Related-party transactions

No related-party transactions disclosed